Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in Eur Heart J

Retrieve available abstracts of 175 articles:
HTML format
Text format



Single Articles


    March 2018
  1. AUFFRET V, Cottin Y, Leurent G, Gilard M, et al
    Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.
    Eur Heart J. 2018 Mar 15. pii: 4938779. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. DAI J, Xing L, Jia H, Zhu Y, et al
    In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study.
    Eur Heart J. 2018 Mar 13. pii: 4934156. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  3. THYGESEN K, Jaffe AS
    The prognostic impact of periprocedural myocardial infarction and injury.
    Eur Heart J. 2018 Feb 26. pii: 4911112. doi: 10.1093.
    PubMed     Text format    


  4. QAYYUM F, Lauridsen BK, Frikke-Schmidt R, Kofoed KF, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Eur Heart J. 2018 Feb 23. pii: 4907930. doi: 10.1093.
    PubMed     Text format     Abstract available



  5. euro6.5 million award to study impact of ECMO on myocardial infarction patients.
    Eur Heart J. 2018;39:649.
    PubMed     Text format    


  6. WIJNS W, Naber CK
    Reperfusion delay in patients with high-risk ST-segment elevation myocardial infarction: every minute counts, much more than suspected.
    Eur Heart J. 2018 Feb 14. pii: 4855285. doi: 10.1093.
    PubMed     Text format    


  7. SCHOLZ KH, Maier SKG, Maier LS, Lengenfelder B, et al
    Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.
    Eur Heart J. 2018 Feb 14. pii: 4855284. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  8. ZEITOUNI M, Silvain J, Guedeney P, Kerneis M, et al
    Periprocedural myocardial infarction and injury in elective coronary stenting.
    Eur Heart J. 2018 Jan 20. pii: 4815728. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. LUSCHER TF
    ST-segment elevation myocardial infarction: the new ESC Guidelines.
    Eur Heart J. 2018;39:75-78.
    PubMed     Text format    


  10. KIM K, Park SM, Lee K
    Weight gain after smoking cessation does not modify its protective effect on myocardial infarction and stroke: evidence from a cohort study of men.
    Eur Heart J. 2018 Jan 6. pii: 4791953. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  11. KOENIG T, Sedding DG, Wester HJ, Derlin T, et al
    Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging.
    Eur Heart J. 2017 Dec 27. pii: 4780241. doi: 10.1093.
    PubMed     Text format    


  12. MONTONE RA, Niccoli G, Fracassi F, Russo M, et al
    Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests.
    Eur Heart J. 2017 Dec 8. pii: 4710061. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  13. KIM MK, Han K, Kim HS, Park YM, et al
    Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study.
    Eur Heart J. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. THYGESEN K, Jaffe AS
    Detecting myocardial infarction type 2: targetting the right patients.
    Eur Heart J. 2017 Oct 5. doi: 10.1093.
    PubMed     Text format    


  15. MANIWA N, Fujino M, Nakai M, Nishimura K, et al
    Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarction.
    Eur Heart J. 2017 Oct 3. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2017
  16. KOJIMA S, Michikawa T, Ueda K, Sakamoto T, et al
    Asian dust exposure triggers acute myocardial infarction.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. SZUMMER K, Wallentin L, Lindhagen L, Alfredsson J, et al
    Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014.
    Eur Heart J. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. IBANEZ B, James S, Agewall S, Antunes MJ, et al
    2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European S
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format    


  19. KRISTENSEN SD, Maeng M
    Perioperative myocardial infarction: in the twilight zone between surgery and cardiology.
    Eur Heart J. 2017;38:2418-2420.
    PubMed     Text format    


  20. SMILOWITZ NR, Gupta N, Guo Y, Berger JS, et al
    Perioperative acute myocardial infarction associated with non-cardiac surgery.
    Eur Heart J. 2017;38:2409-2417.
    PubMed     Text format     Abstract available


  21. LASSALE C, Tzoulaki I, Moons KGM, Sweeting M, et al
    Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis.
    Eur Heart J. 2017 Aug 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. NEUMANN JT, Sorensen NA, Rubsamen N, Ojeda F, et al
    Discrimination of patients with type 2 myocardial infarction.
    Eur Heart J. 2017 Aug 13. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. PRESCOT E
    Exercise and case fatality in myocardial infarction.
    Eur Heart J. 2017;38:2324.
    PubMed     Text format    


  24. KHAN AR, Golwala H, Tripathi A, Bin Abdulhak AA, et al
    Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis.
    Eur Heart J. 2017 Aug 7. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  25. DE WAHA S, Patel MR, Granger CB, Ohman EM, et al
    Relationship between microvascular obstruction and adverse events following primary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
    Eur Heart J. 2017 Jul 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. HOPEWELL JC, Malik R, Valdes-Marquez E, Worrall BB, et al
    Differential effects of PCSK9 variants on risk of coronary disease and ischaemic stroke.
    Eur Heart J. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. POTHINENI NVK, Subramany S, Kuriakose K, Shirazi LF, et al
    Infections, atherosclerosis, and coronary heart disease.
    Eur Heart J. 2017 Jul 12. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2017
  28. REZVAN A
    Telomeres, oxidative stress, and myocardial infarction.
    Eur Heart J. 2017 Jun 14. doi: 10.1093.
    PubMed     Text format    


  29. BARTUNEK J, Wojakowski W
    Intracoronary autologous bone marrow cell transfer after acute myocardial infarction: abort and refocus.
    Eur Heart J. 2017 Jun 13. doi: 10.1093.
    PubMed     Text format    


    May 2017
  30. VIDAL-PETIOT E, Stebbins A, Chiswell K, Ardissino D, et al
    Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
    Eur Heart J. 2017 May 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. DOLL JA, Li S, Chiswell K, Roe MT, et al
    Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy.
    Eur Heart J. 2017 May 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. SCHUPKE S, Mehilli J
    Less myocardial scar but greater propensity for heart failure: another gender paradox in myocardial infarction.
    Eur Heart J. 2017 May 5. doi: 10.1093.
    PubMed     Text format    


    April 2017
  33. MARGARITIS M, Sanna F, Lazaros G, Akoumianakis I, et al
    Predictive value of telomere length on outcome following acute myocardial infarction: evidence for contrasting effects of vascular vs. blood oxidative stress.
    Eur Heart J. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. WOLLERT KC, Meyer GP, Muller-Ehmsen J, Tschope C, et al
    Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Eur Heart J. 2017 Apr 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  35. CAVALCANTE R, Sotomi Y, Mancone M, Whan Lee C, et al
    Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials.
    Eur Heart J. 2017 Apr 18. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. KOSMIDOU I, Redfors B, Selker HP, Thiele H, et al
    Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized t
    Eur Heart J. 2017 Apr 12. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. ALFONSO F, Jimenez-Borreguero LJ
    Optimizing dual antiplatelet therapy duration after myocardial infarction: evidence-based, precision, or personalized medicine?
    Eur Heart J. 2017;38:1056-1059.
    PubMed     Text format    


  38. VRANCKX P, Frigoli E, Rothenbuhler M, Tomassini F, et al
    Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation.
    Eur Heart J. 2017;38:1069-1080.
    PubMed     Text format     Abstract available


  39. GABET A, Danchin N, Juilliere Y, Olie V, et al
    Acute coronary syndrome in women: rising hospitalizations in middle-aged French women, 2004-14.
    Eur Heart J. 2017;38:1060-1065.
    PubMed     Text format     Abstract available


  40. PALMERINI T, Della Riva D, Benedetto U, Bacchi Reggiani L, et al
    Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
    Eur Heart J. 2017;38:1034-1043.
    PubMed     Text format     Abstract available


  41. GEBHARD C
    Women and acute coronary syndromes: still up to no good.
    Eur Heart J. 2017;38:1066-1068.
    PubMed     Text format    


  42. ONUMA Y, Serruys PW
    Freedom from long DAPT signals the demise of the bare-metal stent.
    Eur Heart J. 2017;38:970-973.
    PubMed     Text format    


  43. CARLSSON M
    The impacts on healthcare when coronary angiography as the reference method for diagnostic accuracy of coronary artery disease is replaced by fractional flow reserve!
    Eur Heart J. 2017;38:999-1001.
    PubMed     Text format    


    March 2017
  44. VALGIMIGLI M, Costa F, Lokhnygina Y, Clare RM, et al
    Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.
    Eur Heart J. 2017;38:804-810.
    PubMed     Text format     Abstract available


  45. LI XS, Obeid S, Klingenberg R, Gencer B, et al
    Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
    Eur Heart J. 2017;38:814-824.
    PubMed     Text format     Abstract available


  46. JIA H, Dai J, Hou J, Xing L, et al
    Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study).
    Eur Heart J. 2017;38:792-800.
    PubMed     Text format     Abstract available


    February 2017
  47. PASEA L, Chung SC, Pujades-Rodriguez M, Moayyeri A, et al
    Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors.
    Eur Heart J. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. LYALL DM, Celis-Morales CA, Anderson J, Gill JM, et al
    Associations between single and multiple cardiometabolic diseases and cognitive abilities in 474 129 UK Biobank participants.
    Eur Heart J. 2017;38:577-583.
    PubMed     Text format     Abstract available


  49. MORTENSEN MB, Nordestgaard BG, Afzal S, Falk E, et al
    ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
    Eur Heart J. 2017;38:586-594.
    PubMed     Text format     Abstract available


  50. DEFILIPPIS AP, Young R, McEvoy JW, Michos ED, et al
    Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern
    Eur Heart J. 2017;38:598-608.
    PubMed     Text format     Abstract available


  51. BEBB O, Hall M, Fox KA, Dondo TB, et al
    Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischaemia National Audit Project (MINAP) register.
    Eur Heart J. 2017 Feb 20. doi: 10.1093.
    PubMed     Text format     Abstract available


  52. MATHUR A, Fernandez-Aviles F, Dimmeler S, Hauskeller C, et al
    The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.
    Eur Heart J. 2017 Feb 15. doi: 10.1093.
    PubMed     Text format    


  53. ODAKA Y, Takahashi J, Tsuburaya R, Nishimiya K, et al
    Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries.
    Eur Heart J. 2017;38:489-496.
    PubMed     Text format     Abstract available


  54. KARAKAS M, Schulte C, Appelbaum S, Ojeda F, et al
    Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study.
    Eur Heart J. 2017;38:516-523.
    PubMed     Text format     Abstract available


  55. MOTWANI M, Dey D, Berman DS, Germano G, et al
    Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis.
    Eur Heart J. 2017;38:500-507.
    PubMed     Text format     Abstract available


  56. PRIES AR, Reglin B
    Coronary microcirculatory pathophysiology: can we afford it to remain a black box?
    Eur Heart J. 2017;38:478-488.
    PubMed     Text format     Abstract available


  57. NIELSEN LH, Botker HE, Sorensen HT, Schmidt M, et al
    Prognostic assessment of stable coronary artery disease as determined by coronary computed tomography angiography: a Danish multicentre cohort study.
    Eur Heart J. 2017;38:413-421.
    PubMed     Text format     Abstract available


  58. VAN DER VALK FM, Kuijk C, Verweij SL, Stiekema LCA, et al
    Increased haematopoietic activity in patients with atherosclerosis.
    Eur Heart J. 2017;38:425-432.
    PubMed     Text format     Abstract available


  59. BOURANTAS CV, Jaffer FA, Gijsen FJ, van Soest G, et al
    Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology.
    Eur Heart J. 2017;38:400-412.
    PubMed     Text format     Abstract available


  60. LEIPSIC J, Blanke P
    Prognostic value of coronary CT angiography: lessons from the West Denmark Cardiac Registry.
    Eur Heart J. 2017;38:422-424.
    PubMed     Text format    


  61. CIMATO TR
    Persistent stem cell-driven inflammation in patients with prior MI and stroke.
    Eur Heart J. 2017;38:433-435.
    PubMed     Text format    


    January 2017
  62. ARGACHA JF
    Air pollution and myocardial infarction.
    Eur Heart J. 2017;38:141.
    PubMed     Text format    


  63. ROSENGREN A, Ulin K
    Case fatality in coronary heart disease: the art of counting.
    Eur Heart J. 2017;38:181-183.
    PubMed     Text format    


  64. FRODERMANN V, Nahrendorf M
    Neutrophil-macrophage cross-talk in acute myocardial infarction.
    Eur Heart J. 2017;38:198-200.
    PubMed     Text format    


  65. TOFIELD A
    Myocardial infarction patients are more depressed but receive less antidepressants.
    Eur Heart J. 2017;38:142.
    PubMed     Text format    


  66. AGEWALL S, Beltrame JF, Reynolds HR, Niessner A, et al
    ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.
    Eur Heart J. 2017;38:143-153.
    PubMed     Text format    


  67. ZEYMER U, Ludman P, Danchin N, Kala P, et al
    The European Society of Cardiology ACCA-EAPCI Registry on ST elevation myocardial infarction.
    Eur Heart J. 2017;38:138-139.
    PubMed     Text format    


  68. HORCKMANS M, Ring L, Duchene J, Santovito D, et al
    Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype.
    Eur Heart J. 2017;38:187-197.
    PubMed     Text format    


  69. GALLET R, Dawkins J, Valle J, Simsolo E, et al
    Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Eur Heart J. 2017;38:201-211.
    PubMed     Text format    


  70. TOFIELD A
    Cold weather and myocardial infarction.
    Eur Heart J. 2017;38:140.
    PubMed     Text format    


    December 2016
  71. KHANJI MY, Ninan T, Abdul F, Ionescu A, et al
    Congenital 'bifid' left ventricular apex masquerading as pseudo-aneurysm following acute myocardial infarction.
    Eur Heart J. 2016 Dec 27. pii: ehw524. doi: 10.1093.
    PubMed     Text format    


  72. JAKOB P, Kacprowski T, Briand-Schumacher S, Heg D, et al
    Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction.
    Eur Heart J. 2016 Dec 23. pii: ehw563. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. BARTUNEK J, Terzic A, Davison BA, Filippatos GS, et al
    Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.
    Eur Heart J. 2016 Dec 23. pii: ehw543. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. SCHIELE F
    Quality indicators for acute myocardial infarction.
    Eur Heart J. 2016;37:3549-3550.
    PubMed     Text format    


    November 2016
  75. CREA F, Jaffe AS, Collinson PO, Hamm CW, et al
    Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?
    Eur Heart J. 2016;37:3316-3323.
    PubMed     Text format    



  76. Recent hospitalization trends for acute myocardial infarction in Beijing.
    Eur Heart J. 2016;37:3188-3189.
    PubMed     Text format    


  77. FERREIRA D, Davies A, Thiruchelvam T, Wark P, et al
    Acute myocardial infarction in disseminated mucormycosis infection.
    Eur Heart J. 2016.
    PubMed     Text format    


    October 2016

  78. Dietary patterns and the secondary prevention of coronary heart disease.
    Eur Heart J. 2016;37:2971-2973.
    PubMed     Text format    


    September 2016
  79. GALLET R, Dawkins J, Valle J, Simsolo E, et al
    Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  80. RYAN N, Gonzalo N, Freitas-Ferraz A, Martinez P, et al
    Repetitive vasospasm as a cause of plaque rupture and myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    


  81. ABRAHAM G, Havulinna AS, Bhalala OG, Byars SG, et al
    Genomic prediction of coronary heart disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    August 2016
  82. YAMAJI K, Raber L, Zanchin T, Spitzer E, et al
    Ten-year clinical outcomes of first-generation drug-eluting stents: the Sirolimus-Eluting vs. Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  83. BABER U, Farkouh ME, Arbel Y, Muntner P, et al
    Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  84. EISEN A, Cannon CP, Blazing MA, Bohula EA, et al
    The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    July 2016
  85. SAHLEN A, Varenhorst C, Lagerqvist B, Renlund H, et al
    Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  86. VAN HOUT GP, Bosch L, Ellenbroek GH, de Haan JJ, et al
    The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    June 2016
  87. TWERENBOLD R, Jaeger C, Rubini Gimenez M, Wildi K, et al
    Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  88. HEUSCH G, Gersh BJ
    The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  89. PICA S, Ballestrero G, Pistis G, Crimi G, et al
    Acute stent thrombosis unveils two electrocardiogram patterns in a patient with 'De Winter T-waves' anterior myocardial infarction.
    Eur Heart J. 2016.
    PubMed     Text format    


    May 2016
  90. KLEVELAND O, Kunszt G, Bratlie M, Ueland T, et al
    Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


    April 2016
  91. MORI H, Joner M, Finn AV, Virmani R, et al
    Malapposition: is it a major cause of stent thrombosis?
    Eur Heart J. 2016;37:1217-9.
    PubMed     Text format    


  92. PONTONE G
    Anatomy and physiology in ischaemic heart disease: a second honeymoon?
    Eur Heart J. 2016;37:1228-31.
    PubMed     Text format    


  93. GAUR S, Ovrehus KA, Dey D, Leipsic J, et al
    Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions.
    Eur Heart J. 2016;37:1220-7.
    PubMed     Text format     Abstract available


  94. SOUTEYRAND G, Amabile N, Mangin L, Chabin X, et al
    Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.
    Eur Heart J. 2016;37:1208-16.
    PubMed     Text format     Abstract available


  95. LUBBERS M, Dedic A, Coenen A, Galema T, et al
    Calcium imaging and selective computed tomography angiography in comparison to functional testing for suspected coronary artery disease: the multicentre, randomized CRESCENT trial.
    Eur Heart J. 2016;37:1232-43.
    PubMed     Text format     Abstract available


  96. SMISETH OA, Torp H, Opdahl A, Haugaa KH, et al
    Myocardial strain imaging: how useful is it in clinical decision making?
    Eur Heart J. 2016;37:1196-207.
    PubMed     Text format     Abstract available


  97. GURBEL PA, Tantry US
    Deciding about prolonged ticagrelor therapy in coronary clot formers: an ongoing dilemma.
    Eur Heart J. 2016;37:1143-4.
    PubMed     Text format    


  98. TERZIC A, Behfar A
    CardioPulse: Regenerative medicine in the practice of cardiology.
    Eur Heart J. 2016;37:1089-90.
    PubMed     Text format    


  99. LUSCHER TF
    Coronary and peripheral interventions: an update.
    Eur Heart J. 2016;37:1085-7.
    PubMed     Text format    


  100. PLACIDO R, Almeida AG, Canas da Silva P, Pinto F, et al
    Left main ostial agenesis and right coronary artery occlusion: the importance of the 'Vieussens' arterial ring'.
    Eur Heart J. 2016;37:1170.
    PubMed     Text format    


  101. GOTO K, Kasama S, Sato M, Kurabayashi M, et al
    Myocardial scintigraphic evidence of Kounis syndrome: what is the aetiology of acute coronary syndrome?
    Eur Heart J. 2016;37:1157.
    PubMed     Text format    


  102. KIRSCHFINK A, Frick M, Reinartz S, Becker M, et al
    An undiagnosed double aortic arch hampers a coronary angiography in a patient with LIMA graft.
    Eur Heart J. 2016;37:1169.
    PubMed     Text format    


  103. KIKKERT WJ, Tijssen JG, Piek JJ, Henriques JP, et al
    Challenges in the adjudication of major bleeding events in acute coronary syndrome: a plea for a standardized approach and guidance to adjudication.
    Eur Heart J. 2016;37:1104-12.
    PubMed     Text format    


  104. BONACA MP, Bhatt DL, Steg PG, Storey RF, et al
    Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.
    Eur Heart J. 2016;37:1133-42.
    PubMed     Text format     Abstract available


  105. GUTIERREZ JA, Harrington RA, Blankenship JC, Stone GW, et al
    The effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
    Eur Heart J. 2016;37:1122-30.
    PubMed     Text format     Abstract available


  106. MADONNA R, Van Laake LW, Davidson SM, Engel FB, et al
    Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
    Eur Heart J. 2016.
    PubMed     Text format     Abstract available


  107. SINNAEVE PR, Van de Werf F
    Transporting STEMI patients for primary PCI: a long and winding road paved with good intentions?
    Eur Heart J. 2016;37:1041-3.
    PubMed     Text format    


  108. TAYLOR J
    CardioPulse. Leaders in cardiovascular medicine today. Peter Libby MD.
    Eur Heart J. 2016;37:1008-9.
    PubMed     Text format    


  109. SCHMIDT M, Lamberts M, Olsen AM, Fosboll E, et al
    Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
    Eur Heart J. 2016;37:1015-23.
    PubMed     Text format    


  110. HAGIKURA A, Goto K, Takebayashi H, Haruta S, et al
    Unintentional extraction of a platinum-chromium everolimus-eluting stent by entanglement with a covered stent.
    Eur Heart J. 2016;37:1083.
    PubMed     Text format    


  111. NICCOLI G, Scalone G, Lerman A, Crea F, et al
    Coronary microvascular obstruction in acute myocardial infarction.
    Eur Heart J. 2016;37:1024-33.
    PubMed     Text format     Abstract available


  112. CARRICK D, Haig C, Rauhalammi S, Ahmed N, et al
    Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors.
    Eur Heart J. 2016;37:1044-59.
    PubMed     Text format     Abstract available


    March 2016
  113. LUSCHER TF, Sudano I
    SPRINT: the race for optimal blood pressure control.
    Eur Heart J. 2016;37:937-41.
    PubMed     Text format    


  114. LEWIS BS
    CardioPulse: Coronary artery disease from prevention to intervention.
    Eur Heart J. 2016;37:866-7.
    PubMed     Text format    


  115. SVENSSON T, Inoue M, Sawada N, Yamagishi K, et al
    Coping strategies and risk of cardiovascular disease incidence and mortality: the Japan Public Health Center-based prospective Study.
    Eur Heart J. 2016;37:890-9.
    PubMed     Text format     Abstract available


  116. FERNANDEZ-VEGA A, Vilacosta I, Vedia OA, Pedraja I, et al
    A 'kidnapper' left circumflex coronary artery.
    Eur Heart J. 2016;37:919.
    PubMed     Text format    


  117. STOEKENBROEK RM, Boekholdt SM, Luben R, Hovingh GK, et al
    Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study.
    Eur Heart J. 2016;37:880-9.
    PubMed     Text format     Abstract available


  118. RANTHE MF, Diaz LJ, Behrens I, Bundgaard H, et al
    Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort studydagger.
    Eur Heart J. 2016;37:900-7.
    PubMed     Text format     Abstract available


  119. NAHRENDORF M, Swirski FK
    Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction?
    Eur Heart J. 2016;37:868-72.
    PubMed     Text format     Abstract available


  120. ZHENG SL, Myerson SG, Orchard E
    Partial atrioventricular septal defect presenting in a septuagenarian.
    Eur Heart J. 2016;37:917.
    PubMed     Text format    


  121. BONAPACE S, Adamo E, Ciccio C, Chiampan A, et al
    Unusual echocardiographic image of a left circumflex coronary artery with anomalous origin from the right coronary sinus.
    Eur Heart J. 2016;37:792.
    PubMed     Text format    


  122. JORGE C, Canas da Silva P, Lousada N, Pinto FJ, et al
    Effort syncope and pencil-point left main coronary artery: cause or unsual finding?
    Eur Heart J. 2016;37:744.
    PubMed     Text format    


    February 2016
  123. ACHENBACH S
    CardioPulse: The future of coronary computer tomography angiography.
    Eur Heart J. 2016;37:661-3.
    PubMed     Text format     Abstract available


  124. WATABE H, Sato A, Nishina H, Hoshi T, et al
    Enhancement patterns detected by multidetector computed tomography are associated with microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction.
    Eur Heart J. 2016;37:684-92.
    PubMed     Text format     Abstract available


  125. LUSCHER TF
    Improving prevention: risk scores, imaging, and PCSK9 inhibitors.
    Eur Heart J. 2016;37:499-501.
    PubMed     Text format    


  126. KOSKINAS KC, Ughi GJ, Windecker S, Tearney GJ, et al
    Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment.
    Eur Heart J. 2016;37:524-35a-c.
    PubMed     Text format     Abstract available


  127. GENCER B, Montecucco F, Nanchen D, Carbone F, et al
    Prognostic value of PCSK9 levels in patients with acute coronary syndromes.
    Eur Heart J. 2016;37:546-53.
    PubMed     Text format     Abstract available


  128. TADA H, Melander O, Louie JZ, Catanese JJ, et al
    Risk prediction by genetic risk scores for coronary heart disease is independent of self-reported family history.
    Eur Heart J. 2016;37:561-7.
    PubMed     Text format     Abstract available


  129. LECLERCQ C, Dievart F, Ruschitzka F
    Peri-infarct pacing to prevent left reverse remodelling: an unvalidated concept?
    Eur Heart J. 2016;37:494-5.
    PubMed     Text format    


  130. DIMARCO A, Mansoubi H, Tanner M
    An unusual cause of left ventricular hypertrophy.
    Eur Heart J. 2016;37:497.
    PubMed     Text format    


  131. STONE GW, Chung ES, Stancak B, Svendsen JH, et al
    Peri-infarct zone pacing to prevent adverse left ventricular remodelling in patients with large myocardial infarction.
    Eur Heart J. 2016;37:484-93.
    PubMed     Text format     Abstract available


    January 2016
  132. DANCHIN N, Puymirat E, Schiele F
    Antithrombotic therapy for stable coronary artery disease: the difficult quest for the holy balance.
    Eur Heart J. 2016;37:409-11.
    PubMed     Text format    


  133. TOFIELD A
    CardioPulse:Thrombus aspiration does not improve 12-month outcomes.
    Eur Heart J. 2016;37:331-2.
    PubMed     Text format    


  134. VERHEUGT FW
    CardioPulse: Triple therapy for percutaneous coronary intervention in atrial fibrillation: a nightmare.
    Eur Heart J. 2016;37:326-7.
    PubMed     Text format    


  135. COLOMBO A, Jabbour RJ
    CardioPulse: The future of percutaneous coronary interventions.
    Eur Heart J. 2016;37:322-3.
    PubMed     Text format    


  136. PALMERINI T, Stone GW
    Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.
    Eur Heart J. 2016;37:353-64.
    PubMed     Text format     Abstract available


  137. GURBEL PA, Tantry US
    CardioPulse: Platelet inhibitors and their differences.
    Eur Heart J. 2016;37:323-6.
    PubMed     Text format    


  138. LUSCHER TF
    The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration.
    Eur Heart J. 2016;37:319-21.
    PubMed     Text format    


  139. ROE MT, Cyr DD, Eckart D, Schulte PJ, et al
    Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
    Eur Heart J. 2016;37:412-22.
    PubMed     Text format     Abstract available


  140. MARTI D, Moya JL, Cuevas A, Zamorano JL, et al
    A rare cause of tough coronary occlusion.
    Eur Heart J. 2016;37:343.
    PubMed     Text format    


  141. AL-LAMEE R, Davies JE, Gerber R
    An unusual complication of coronary angiography via the radial approach.
    Eur Heart J. 2016;37:385.
    PubMed     Text format    


  142. MAGNANI G, Storey RF, Steg G, Bhatt DL, et al
    Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
    Eur Heart J. 2016;37:400-8.
    PubMed     Text format     Abstract available


  143. HELFT G, Steg PG, Le Feuvre C, Georges JL, et al
    Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial.
    Eur Heart J. 2016;37:365-74.
    PubMed     Text format     Abstract available


  144. UDELL JA, Bonaca MP, Collet JP, Lincoff AM, et al
    Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials.
    Eur Heart J. 2016;37:390-9.
    PubMed     Text format     Abstract available


  145. MONTALESCOT G, Sabatine MS
    Oral dual antiplatelet therapy: what have we learnt from recent trials?
    Eur Heart J. 2016;37:344-52.
    PubMed     Text format     Abstract available


  146. HAFLIGER M, Weilenmann D, Rickli H, Maeder MT, et al
    Recurrent left anterior descending artery spasm causing transmural ischaemia treated with stenting.
    Eur Heart J. 2016;37:364.
    PubMed     Text format    


  147. TOFIELD A
    CardioPulse: Exercise and stop smoking to improve depression after myocardial infarction.
    Eur Heart J. 2016;37:214-5.
    PubMed     Text format    


  148. NICHOLLS M
    CardioPulse: Cyclosporine to reduce myocardial infarction injury?
    Eur Heart J. 2016;37:210-1.
    PubMed     Text format    


  149. LANZER C, Lanzer P
    CardioPulse: Angina pectoris revisited.
    Eur Heart J. 2016;37:215.
    PubMed     Text format    


  150. MOTOVSKA Z
    CardioPulse: Quality measures in acute coronary syndromes.
    Eur Heart J. 2016;37:209-10.
    PubMed     Text format    


  151. ROFFI M, Patrono C
    CardioPulse: 'Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS).
    Eur Heart J. 2016;37:208.
    PubMed     Text format    


  152. ROFFI M, Patrono C, Zamorano JL
    CardioPulse: What's new in the 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
    Eur Heart J. 2016;37:206-7.
    PubMed     Text format    


  153. LUSCHER TF
    The management of acute coronary syndromes: towards optimal treatment of STEMI and non-STEMI.
    Eur Heart J. 2016;37:203-5.
    PubMed     Text format    


  154. MONTALESCOT G, Crea F
    The year in cardiology 2015: acute coronary syndromes.
    Eur Heart J. 2016;37:221-8.
    PubMed     Text format    


  155. KUBICA J, Adamski P, Ostrowska M, Sikora J, et al
    Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.
    Eur Heart J. 2016;37:245-52.
    PubMed     Text format     Abstract available


  156. CHOUDRY F, Hamshere S, Saunders N, Veerapen J, et al
    A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trialdagger.
    Eur Heart J. 2016;37:256-63.
    PubMed     Text format     Abstract available


  157. SABATE M, Windecker S, Iniguez A, Okkels-Jensen L, et al
    Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
    Eur Heart J. 2016;37:229-40.
    PubMed     Text format     Abstract available


  158. KUMAR V, Varghese MJ, Raveendran S, George OK, et al
    Pseudoaneurysm following transradial coronary angiogram.
    Eur Heart J. 2016;37:252.
    PubMed     Text format    


  159. ROFFI M, Patrono C, Collet JP, Mueller C, et al
    2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation
    Eur Heart J. 2016;37:267-315.
    PubMed     Text format    


  160. HEUSCH G, Gersh BJ
    ERICCA and RIPHeart: two nails in the coffin for cardioprotection by remote ischemic conditioning? Probably not!
    Eur Heart J. 2016;37:200-2.
    PubMed     Text format    


  161. KOMAJDA M, Weidinger F, Kerneis M, Cosentino F, et al
    EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT).
    Eur Heart J. 2016;37:152-60.
    PubMed     Text format     Abstract available


  162. SALEH Y, AlMaghraby A, Haggag A, Hammad B, et al
    An inferior vena cava filter causing perforation with all six legs.
    Eur Heart J. 2016;37:163.
    PubMed     Text format    


  163. STEG PG, Serruys PW, Abdelghani M, Wijns W, et al
    The year in cardiology 2015: coronary intervention.
    Eur Heart J. 2016.
    PubMed     Text format    


    December 2015
  164. KARIMI GALOUGAHI K, Zalewski A, Leon MB, Karmpaliotis D, et al
    Optical coherence tomography-guided percutaneous coronary intervention in pre-terminal chronic kidney disease with no radio-contrast administration.
    Eur Heart J. 2015.
    PubMed     Text format    


  165. RYAN N, Terol B, Grande-Ingelmo JM, Escaned J, et al
    Persistent post percutaneous coronary intervention angina investigated with invasive physiological testing.
    Eur Heart J. 2015.
    PubMed     Text format    


  166. LUSCHER TF
    Deciding on coronary intervention: which lesion, which stent?
    Eur Heart J. 2015;36:3301-3.
    PubMed     Text format    


    November 2015
  167. MANCIA G, Kjeldsen SE, Zappe DH, Holzhauer B, et al
    Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  168. MAURI L, Elmariah S, Yeh RW, Cutlip DE, et al
    Causes of late mortality with dual antiplatelet therapy after coronary stents.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    September 2015
  169. ZIMMERMANN FM, Ferrara A, Johnson NP, van Nunen LX, et al
    Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  170. FOX K, Ford I, Steg PG, Tardif JC, et al
    Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    August 2015
  171. PRIORI SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, et al
    2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Eu
    Eur Heart J. 2015.
    PubMed     Text format    


  172. BARBASH IM, Barbanti M, Webb J, Molina-Martin De Nicolas J, et al
    Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


  173. LEITMAN M, Shmueli R, Rubchevsky V, Hendler A, et al
    A 45-year-old woman with chest pain after coronary stenting.
    Eur Heart J. 2015.
    PubMed     Text format    


  174. WIJNS W, Shite J, Jones MR, Lee SW, et al
    Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study.
    Eur Heart J. 2015.
    PubMed     Text format     Abstract available


    June 2015
  175. YSSAP J, Lebreton G, Hoen B, Larifla L, et al
    Infected left ventricular thrombus revealing an unrecognized coronary dissection after blunt chest trauma, treated with emergency heart transplantation.
    Eur Heart J. 2015.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: